|Day Low/High||3.58 / 3.84|
|52 Wk Low/High||1.87 / 8.13|
The most recent short interest data has been released by the NASDAQ for the 01/31/2014 settlement date, which shows a 643,936 share increase in total short interest for Amyris, Inc. , to 6,258,284, an increase of 11.47% since 01/15/2014.
Amyris Selects Dowell as Squalane Distributor in Korea to Meet Growing Demand for Best-in-Class Emollient
First Purpose-Built Industrial-Scale Plant Completes First Year of Successful Operation in Brazil
Total Amyris BioSolutions Established Produce and Commercialize Renewable Fuels From Amyris's Technology Platform
Paulo Diniz, Current President of Brazil Operations, to Become Amyris's CFO Upon Retirement of Steve Mills in December
Continued Strong Operational Performance and Lower Production Costs Lead to Another Strong Quarter for Amyris
Leading Airline in Brazil Seeks to Use Amyris's Sugarcane-Derived Jet Fuel Following Industry Validation and Regulatory Approvals
Amyris CEO to Speak at Advanced Biofuels Leadership Conference on Strong Performance of Amyris's Renewable Hydrocarbon Production in Brazil
Record Renewable Products Sales and Continued Progress at Farnesene Production Facility
Proceeds From Sale of Convertible Notes to Provide Financial Flexibility as Amyris Scales Up Production and Commercial Sales of Renewable Hydrocarbons
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of investors who purchased Amyris, Inc.
Investors considering a purchase of Amyris, Inc. shares, but tentative about paying the going market price of $2.78/share, might benefit from considering selling puts among the alternative strategies at their disposal.
First Demonstration Flight in Europe on Airbus Aircraft Underscores Partners' Commitment to Achieving ASTM Certification
Patrick Pichette Steps Down but Will Remain a Strategic Advisor
Operating Expenses Down by 29% From the First Quarter of 2012, With Continued Revenue Improvement and Steady Business Execution
Amyris Breakthrough Industrial Biosynthesis Technology Platform to Reduce Supply Volatility of Critical Ingredients for the Aroma Industry
Laserson Brings In-Depth Experience in Squalane Distribution to European Cosmetics Market
Sanofi Utilizing Amyris Engineered Yeast Strains to Produce Life-Saving Drug Ingredient at Scale
The top 10 open-market insider purchases and sales filed at the SEC Friday.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.